Tesamorelin

  • Part D specialty tier in 79% of formularies (2026Q3)
  • Biologic
  • EGRIFTA SV

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Tesamorelin: storage and handling

Freezing
Not addressed
Room temperature
at or below 30°C (86°F)
Label statement
Store EGRIFTA SV 2 mg vial at room temperature at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].
Room temperature
at or below 25°C (77°F)
Label statement
Store the Injection box (containing Sterile Water for Injection, syringes and needles) at room temperature at 20°C to 25°C (68°F to 77°F).
Room temperature
at or below 25°C (77°F)
Label statement
You will be given 2 boxes from the pharmacy when you get your prescription of EGRIFTA SV: Store the 2 mg EGRIFTA SV vials in the Medication Box they come in, at room temperature between 68°F to 77°F (20°C to 25°C).
Room temperature
at or below 25°C (77°F)
Label statement
Store the Sterile Water for Injection, syringes and needles that come in the Injection Box at room temperature between 68°F to 77°F (20°C to 25°C).
Room temperature
at or below 25°C (77°F)
Label statement
You will be given two boxes from the pharmacy when you get your prescription of EGRIFTA SV: o Store the 2 mg EGRIFTA SV vials in the Medication Box they come in, at room temperature at 20°C to 25°C (68°F to 77°F). o Store the Sterile Water for Injection, syringes and needles that come in the Injection Box at room temperature at 20°C to 25°C (68°F to 77°F).
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Store EGRIFTA SV 2 mg vial at room temperature at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-833-23THERA (1-833-238-4372) (the number printed on the label) about this product.

Where the label prints this number
If you are missing any supplies from the boxes given to you by the pharmacy or if any of the supplies look damaged, call your pharmacist or contact toll-free at 1-833-23THERA (1-833-238-4372) right away.
All storage statements on the label (7)
  • Store EGRIFTA SV 2 mg vial at room temperature at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].
  • Store the Injection box (containing Sterile Water for Injection, syringes and needles) at room temperature at 20°C to 25°C (68°F to 77°F).
  • You will be given 2 boxes from the pharmacy when you get your prescription of EGRIFTA SV: Store the 2 mg EGRIFTA SV vials in the Medication Box they come in, at room temperature between 68°F to 77°F (20°C to 25°C).
  • Store the Sterile Water for Injection, syringes and needles that come in the Injection Box at room temperature between 68°F to 77°F (20°C to 25°C).
  • Do not store, freeze or refrigerate EGRIFTA SV after it has been mixed with the Sterile Water.
  • Do not use EGRIFTA SV after the expiration date (EXP) printed on the carton and vial labels.
  • You will be given two boxes from the pharmacy when you get your prescription of EGRIFTA SV: o Store the 2 mg EGRIFTA SV vials in the Medication Box they come in, at room temperature at 20°C to 25°C (68°F to 77°F). o Store the Sterile Water for Injection, syringes and needles that come in the Injection Box at room temperature at 20°C to 25°C (68°F to 77°F).

FDA label version 9, effective July 29, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

4%of plans list it
51%of those: prior authorization
0%step therapy
34%quantity limit
96%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.